Abstract:Key PointsFocal adhesion kinase (FAK) is a scaffold and kinase protein that binds to itself and cellular partners through its four-point-one, ezrin, radixin, moesin (FERM) domain. Recent data on FAK structure and the sequence of activation have been deduced, largely from crystallographic and biosensor studies. These data have revealed that the activation sequence involves the release of FERM–kinase interactions, subsequent conformational changes, protein binding and key phosphorylation events at specific subcellular locations.The FERM domain of FAK binds to cellular protein and lipid partners, and these are variously involved in catalytic activation and/or recruitment of FAK into macromolecular complexes in cells — predominantly at cortical adhesion structures, but also in the nucleus.Among cytoplasmic FAK FERM domain binding partners recognized thus far are: phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2; generated by the action of phosphatidylinositol-4-phosphate 5-kinase type-1γ (PtdIns(4)P5KIγ)), which binds to the FERM domain and may trigger the activation cascade, perhaps along with molecular clustering, actin-related protein 3 (ARP3), receptor for activated kinase C 1 (RACK1), epidermal growth factor receptor (EGFR), c-Met, ezrin, epithelial and endothelial tyrosine kinase (ETK; also known as BMX), possibly insulin receptor substrate 1 (IRS1), JNK/SAPK-associated protein 1 (JSAP1; also known as JIP3) , and the β subunits of integrin cell–extracellular matrix receptors.FAK is required for optimal signalling from the tyrosine kinase receptors EGFR and c-Met, and modulates cortical actin and nascent adhesions by binding to the ARP2/3 complex and the molecular scaffold RACK1. The FERM domain is implicated in these important FAK functions.The FERM domains of FAK and PYK2 also bind to the tumour suppressor protein p53 and its regulator MDM2 in the nucleus on receipt of stress signals such as cell detachment. p53 degradation and survival can be promoted through these FERM-mediated interactions.The findings above imply that the FAK FERM domain may control and coordinate cellular responses at the cell cortex and in the nucleus, potentially linking regulation of cell migration with the life and death choices that cells have to make. We speculate that the FERM domain may act as a 'sensor' and 'shuttle' of information and events occurring in and between distinct subcellular locations. From data in the literature on other FERM domain-containing proteins (FDCPs) and from sequence gazing, we speculate that a 'cortex to nuclear' information shuttle may be a more general function of FERM domains in biology, which could be exploited for therapy.

The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions

Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation

Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders

Janus Kinases (jaks): the Efficient Therapeutic Targets for Autoimmune Diseases and Myeloproliferative Disorders.

Promiscuous Janus kinase binding to cytokine receptors modulates signaling efficiencies and contributes to cytokine pleiotropy

Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity.

The FERM domain: organizing the structure and function of FAK

Role of Jak kinases and STATs in cytokine signal transduction

Revisiting Structure-activity Relationships: Unleashing the potential of selective Janus kinase 1 inhibitors

The Membrane-Proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by Jak2-Dependent and -Independent Mechanisms

The JAK-STAT pathway: from structural biology to cytokine engineering

JAK1: Number one in the family; number one in inflammation?

A new protein containing an SH2 domain that inhibits JAK kinases

A novel approach to study multi-domain motions in JAK1's activation mechanism based on energy landscape

Deciphering the molecular choreography of Janus kinase 2 inhibition via Gaussian accelerated molecular dynamics simulations: a dynamic odyssey

Crystal Structure of the FERM Domain of Focal Adhesion Kinase*

FERM domain interaction promotes FAK signaling

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers

JAK inhibitor selectivity: new opportunities, better drugs?

Jak2-Stat5 Interactions Analyzed in Yeast*

Structural biology of shared cytokine receptors.